VectivBio Holding AG VECT
16.87 +16.87
Day range unavailable
52-week range unavailable
Financial health
Altman Z-Score
15.07 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -4.1×
FY 2018 5y median -4.1× FY 2022
P/S 14.0×
FY 2018 5y median 0.0× FY 2022
P/B 1.8×
FY 2018 5y median 1.8× FY 2022
P/FCF -6.8×
FY 2018 5y median -6.8× FY 2022
EV/EBITDA -2.1×
FY 2018 5y median -2.1× FY 2022
EV/Sales 6.3×
FY 2018 5y median 0.0× FY 2022
FCF Yield -14.7%
FY 2018 5y median -9.0% FY 2022
Profitability
Gross Margin 100.0%
FY 2018 5y median 0.0% FY 2022
Operating Margin -294.5%
FY 2018 5y median 0.0% FY 2022
Net Margin -342.8%
FY 2018 5y median 0.0% FY 2022
ROE -43.9%
FY 2018 5y median -75.0% FY 2022
ROIC -35.3%
FY 2018 5y median -72.6% FY 2022
ROA -37.1%
FY 2018 5y median -53.6% FY 2022
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2022
Operating Income 7.1%
FY 2018 FY 2022
EPS (diluted) 34.4%
FY 2018 FY 2022
Free Cash Flow 22.0%
FY 2018 FY 2022
Financial Health
Current Ratio 9.1×
FY 2018 5y median 4.0× FY 2022
Quick Ratio 9.1×
FY 2018 5y median 4.0× FY 2022
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2022
Net Debt / EBITDA 2.6×
FY 2018 5y median 0.7× FY 2022
Interest Coverage -25.5×
FY 2018 5y median -103× FY 2022
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31
